Tales of Pacific tangles
Cycad exposure and Guamanian neurodegenerative diseases
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The Chamorros (meaning “chief”), the native people of Guam, came to the Marianas, an archipelago of small mixed volcanic and limestone islands of Micronesia, around 1500 BC. After the end of the Second World War, two unusual conditions were reported with a high prevalence in the Chamorros.1,2 First was amyotrophic lateral sclerosis (ALS) with a relatively early age at onset, and the second was an unusual parkinsonism-dementia complex (PDC). ALS and PDC at times coexisted in the same person. Over the past 50 years, the prevalence of Guamanian ALS declined, as did the prevalence of PDC, although less so. Concurrently there emerged an increased incidence of late-life dementia without parkinsonism, with a phenotype similar to that of Alzheimer disease (AD). However, the pathology was distinct: tauopathy (hyperphosphorylated microtubule associated TAU protein) with neurofibrillary tangles occurred often without neuritic plaques, and not both pathologies together, as usually seen in AD. Consequently, this disorder has been termed Guamanian dementia (GD). Alpha synuclein pathology was also seen, especially with PDC. The temporal trends in the prevalence of Guamanian neurodegenerative diseases (NDD) and the rarity of the diseases in Chamorro populations on other islands suggested the operation of environmental factors, with those most heavily exposed developing ALS, those with intermediate levels of exposure developing PDC, and those with the least exposure developing GD. Studying the dietary habits of the Chamorros, Marjorie Whiting, a cultural anthropologist and nutritionist, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Views and Reviews
The ALS/PDC syndrome of Guam and the cycad hypothesisJohn C. Steele, Patrick L. McGeer et al.Neurology, May 19, 2008 -
Articles
Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of GuamA. R. Borenstein, J. A. Mortimer, E. Schofield et al.Neurology, May 21, 2007 -
ARTICLES
ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, GuamX. Chen, Y. Xia, L. S. Gresham et al.Neurology, September 01, 1996 -
Editorials
Western Pacific ALS/PDC and flying foxesWhat’s next?Carmel Armon et al.Neurology, August 11, 2003